Compound Q&A

What is the market or research trend for Bedaquiline (CAS: 843663-66-1)?

Answer

Bedaquiline
Bedaquiline (CAS: 843663-66-1) continues to see research and development interest, particularly in combination therapies for drug-resistant tuberculosis. Market trends indicate growing demand, especially in regions with high TB prevalence. Research focuses on improving its efficacy, safety, and reducing side effects.

About

English Name Bedaquiline
Molecular Formula C32H31BrN2O2
Molecular Weight 555.52 g/mol
SMILES COc1nc2ccc(cc2cc1[C@H]([C@](c1cccc2c1cccc2)(CCN(C)C)O)c1ccccc1)Br
InChIKey QUIJNHUBAXPXFS-XLJNKUFUSA-N
Last Updated: 2025-09-08 18:31

Related Q&A

Compound Q&A

What regulatory guidelines apply to Bedaquiline (CAS: 843663-66-1)?

Bedaquiline (CAS: 843663-66-1) is regulated under various guidelines, including the Globally Harmoni...

Compound Q&A

Are there alternatives to Bedaquiline (CAS: 843663-66-1) in synthesis?

While Bedaquiline (CAS: 843663-66-1) is a key compound in tuberculosis treatment, there are alternat...

Compound Q&A

How should waste containing Bedaquiline (CAS: 843663-66-1) be handled?

Waste containing Bedaquiline (CAS: 843663-66-1) should be collected in appropriately labeled contain...

Compound Q&A

What is 6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one (CAS: 21889-89-4)?

6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one is a cyclic ketone with a molecular for...

21889-89-46-Methyl-7-oxabicycl...
Compound Q&A

What is 4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid (CAS: 906353-00-2)?

4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid is a chemical compound with the CAS nu...

906353-00-24-[(6-Methyl-2-pyraz...
Compound Q&A

What is 2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8)?

2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8) is a colorless to slightly yel...

49745-42-82-(2-Pyridinyl)-1,3-...
Compound Q&A

What is 2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile (CAS: 24783-42-4)?

2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile is an organic compound with the CA...

24783-42-42-(6-Chloro-2-pyridi...